Antiglycation and antioxidant effect of carnosine against glucose degradation products in peritoneal mesothelial cells

Nephron - Clinical Practice

Volumn 107, Issue 1, 2007, Pages

  Alhamdani, Mohamed Saiel Saeed ^a   Al Kassir, Abdul Hameed A M ^a,b   Abbas, Fawzi K H ^a   Jaleel, Nidham A ^a,b   Al Taee, Maha F ^c  

^a MUSTANSIRIYAH UNIVERSITY   (Iraq)

^b BAGHDAD TEACHING HOSPITAL   (Iraq)

^c AL NAHRAIN UNIVERSITY   (Iraq)

Author keywords

Carnosine; Glucose degradation products; Mesothelial cells; Peritoneal dialysis fluid

Indexed keywords

ANSERINE; BETA ALANINE; CARNOSINE; GLUCOSE DEGRADATION PRODUCT; HISTIDINE; HOMOCARNOSINE; PERITONEAL DIALYSIS FLUID; REACTIVE OXYGEN METABOLITE;

ANTIOXIDANT ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CELL CULTURE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; GLYCATION; HUMAN; HUMAN TISSUE; MESOTHELIUM CELL; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN CARBONYLATION;

ANTIOXIDANTS; CARNOSINE; CELL SURVIVAL; CELLS, CULTURED; EPITHELIUM; GLUCOSE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; PERITONEAL CAVITY;

EID: 34548409920     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000106509     Document Type: Article

References (45)

1. Inagi R, Miyata T: Oxidative protein damage with carbohydrates and lipids in uremia: 'carbonyl stress'. Blood Purif 1999;17:95-98.
2. Lapolla A, Flamini R, Lupo A, Arico NC, Rugiu C, Reitano R, Tubaro M, Ragazzi E, Seraglia R, Traldi P: Evaluation of glyoxal and methylglyoxal levels in uremic patients under peritoneal dialysis. Ann NY Acad Sci 2005;1043:217-224.
3. Miyata T, Kurokawa K, van Ypersele de Strihou C: Advanced glycation and lipoxidation end products: role of reactive carbonyl compounds generated during carbohydrate and lipid metabolism. J Am Soc Nephrol 2000;11:1744-1752.
4. Linden T, Cohen A, Deppisch R, Kjellstrand P, Wieslander A: 3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis. Kidney Int 2002;62:697-703.
5. Alhamdani MSS, Al-Kassir AAM, Jaleel NA, Hmood AM, Ali HM: Elevated levels of alkanals, alkenals and 4-hydroxyalkenals in plasma of hemodialysis patients. Am J Nephrol 2006;26:299-303.
6. Miyata T, van Ypersele de Strihou C, Kurokawa K, Baynes JW: Alterations in non-enzymatic biochemistry in uremia: origin and significance of 'carbonyl stress' in long-term uremic complications. Kidney Int 1999;55:389-399.
7. Nilsson-Thorell CB, Muscalu N, Andrén AH, Kjellstrand PT, Wieslander AP: Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes. Perit Dial Int 1993;13:208-213.
8. Wieslander AP, Andrén AH, Nilsson-Thorell C, Muscalu N, Kjellstrand PT, Rippe B: Are aldehydes in heat-sterilized peritoneal dialysis fluids toxic in vitro? Perit Dial Int 1995;15:348-352.
9. Witowski J, Korybalska K, Wisniewska J, Breborowicz A, Gahl GM, Frei U, Passlick-Deetjen J, Jorres A: Effect of glucose degradation products on human peritoneal mesothelial cell function. J Am Soc Nephrol 2000;11:729-739.
10. Witowski J, Wisniewska J, Korybalska K, Bender TO, Breborowicz A, Gahl GM, Frei U, Passlick-Deetjen J, Jorres A: Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol 2001;12:2434-2441.
11. Breborowicz A, Witowski J, Polubinska A, Pyda M, Oreopoulos D: L-2-Oxothiazolidine-4-carboxylic acid reduces in vitro cytotoxicity of glucose degradation products. Nephrol Dial Transplant 2004;19:3005-3011.
12. Welten AG, Schalkwijk CG, ter Wee PM, Meijer S, van den Born J, Beelen RJ: Single exposure of mesothelial cells to glucose degradation products yields early advanced glycation end products and a proinflammatory response. Perit Dial Int 2003;23:213-221.
13. Inagi R, Miyata T, Yamamoto T, Suzuki D, Urakami K, Saito A, van Ypersele de Strihou C, Kurokawa K: Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis. FEBS Lett 1999;463:260-264.
14. Linden T, Musi B, Jarkelid L, Forsback G, Kjellstrand P, Deppisch R, Wieslander A: Glucose degradation products in peritoneal dialysis fluids may have both local and systemic effects: a study of residual fluid and mesothelial cells. Perit Dial Int 2001;21:607-610.
15. Lage C, Pischetsrieder M, Aufricht C, Jorres A, Schilling H, Passlick-Deetjen J: First in vitro and in vivo experiences with Stay-Safe Balance, a pH-neutral solution in a dual-chambered bag. Perit Dial Int 2000;20(suppl 5):S28-S32.
16. Inagi R, Miyata T, Ueda Y, Yoshino A, Nangaku M, van Ypersele de Strihou C, Kurokawa K: Efficient in vitro lowering of carbonyl stress by the glyoxalase system in conventional glucose peritoneal dialysis fluid. Kidney Int 2002;62:679-687.
17. Ishikawa N, Miyata T, Ueda Y, Inagi R, Izuhara Y, Yuzawa H, Onogi H, Nishina M, Nangaku M, Van Ypersele De Strihou C, Kurokawa K: Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid. Kidney Int 2003;63:331-339.
18. Sakai A, Nakayama M, Numata M, Takesawa S, Nakamoto M: Sodium sulfite and N-acetylcysteine: new additives to dialysate for inhibiting formation of glucose degradation products and advanced glycation end products. Adv Perit Dial 2001;17:66-70.
19. Quinn PJ, Boldyrev AA, Formazuyk VE: Carnosine: its properties, functions and potential therapeutic applications. Mol Aspects Med 1992;13:379-444.
20. Abe H: Role of histidine-related compounds as intracellular proton buffering constituents in vertebrate muscle. Biochemistry (Mosc) 2000;65:757-765.
21. Shimada T, Watanabe N, Ohtsuka Y, Endoh M, Kojima K, Hiraishi H, Terano A: Polaprezinc down-regulates proinflammatory cytokine-induced nuclear factor-κB activation and interleukin-8 expression in gastric epithelial cells. J Pharmacol Exp Ther 1999;291:345-352.
22. Nagai K, Suda T: Realization of spontaneous healing function by carnosine. Methods Find Exp Clin Pharmacol 1988;10:497-507.
23. McFarland GA, Holliday R: Retardation of the senescence of cultured human diploid fibroblasts by carnosine. Exp Cell Res 1994;212:167-175.
24. McFarland GA, Holliday, R: Further evidence for the rejuvenating effects of the dipeptide L-carnosine on cultured human diploid fibroblasts. Exp Geront 1999;34:35-45.
25. Hartman PE, Hartman Z: Direct interception of mutagens and carcinogens by biomolecules. Basic Life Sci 1993;61:351-366.
26. Guiotto A, Calderan A, Ruzza P, Borin G: Carnosine and carnosine-related antioxidants: a review. Curr Med Chem 2005;12:2293-2315.
27. Aldini G, Facino RM, Beretta G, Carini M: Carnosine and related dipeptides as quenchers of reactive carbonyl species: from structural studies to therapeutic perspectives. Biofactors 2005;24:77-87.
28. Price DL, Rhett PM, Thorpe SR, Baynes JW: Chelating activity of advanced glycation end product inhibitors. J Biol Chem 2001;276:48967-48972.
29. Hipkiss AR, Michaelis J, Syrris P: Non-enzymic glycosylation of the dipeptide L-carnosine, a potential anti-protein cross-linking agent. FEBS Lett 1995;371:81-85.
30. Hipkiss AR, Brownson C, Bertani MF, Ruiz E, Ferro A: Reaction of carnosine with aged proteins: another protective process? Ann NY Acad Sci 2002;959:285-294.
31. Seidler NW, Yeargans GS, Morgan TG: Carnosine disaggregates glycated α-crystallin: an in vitro study. Arch Biochem Biophys 2004;427:110-115.
32. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD: Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990;37:1563-1570.
33. Van de Loosdrecht AA, Beelen RH, Ossenkoppele GJ, Broekhoven MG, Langenhuijsen MM: A tetrazolium-based colorimetric MTT assay to quantitate human monocyte-mediated cytotoxicity against leukemic cells from cell lines and patients with acute myeloid leukemia. J Immunol Methods 1994;174:311-320.
34. Vassault, A: Lactate dehydrogenase: UV method with pyruvate and NADH; in Bergmeyer HU, Bergmeyer J, Grassi M (eds): Methods of Enzymatic Analysis. New York, Verlag Chemie/Academic Press, 1983, vol 3, pp 118-126.
35. Hartley DP, Kroll DJ, Petersen DR: Prooxidant-initiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxynonenal- and malondialdehyde-protein adducts. Chem Res Toxicol 1997;10:895-905.
36. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn B, Shaltiel S, Stadtman ER: Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990;186:464-478.
37. GouazéV, Andrieu-Abadie N, Malagarie-Cazenave O, Frisach MF, Mirault ME, Levade T: Glutathione peroxidase-1 protects from CD95-induced apoptosis. J Biol Chem 2002;277:42867-42874.
38. Breborowicz A, Breborowicz M, Oreopoulos DG: Glucose-induced changes in the phenotype of human peritoneal mesothelial cells: effect of L-2-oxothiazolidine carboxylic acid. Am J Nephrol 2003;23:471-476.
39. Hu Y, Ocheltree SM, Xiang J, Keep RF, Smith DE: Glycyl- L-glutamine disposition in rat choroid plexus epithelial cells in primary culture: role of PEPT2. Pharm Res 2005;22:1281-1286.
40. Miyata T, Horie K, Ueda Y, Fujita Y, Izuhara Y, Hirano H, Uchida K, Saito A, van Ypersele de Strihou C, Kurokawa K: Advanced glycation and lipid oxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds. Kidney Int 2000;58:425-435.
41. Alhamdani MSS, Al-Azzawie HF, Abbas FKH: Decreased formation of advanced glycation end products in peritoneal fluid by carnosine and related peptides. Perit Dial Int 2007;27:86-89.
42. Decker EA, Livisay SA, Zhou S: A re-evaluation of the antioxidant activity of purified carnosine. Biochemistry (Mosc) 2000;65:766-770.
43. Boldyrev AA, Dupin AM, Pindel EV, Severin SE: Antioxidative properties of histidine-containing dipeptides from skeletal muscles of vertebrates. Comp Biochem Physiol B 1988;89:245-250.
44. Werynski A, Waniewski J, Wang T, Anderstam B, Lindholm B, Bergstrom J: Kinetic studies of dipeptide-based and amino acid-based peritoneal dialysis solutions. Kidney Int 2001;59:363-371.
45. Bergstrom J, Furst P, Noree LO, Vinnars E: Intracellular free amino acids in muscle tissue of patients with chronic uraemia: effect of peritoneal dialysis and infusion of essential amino acids. Clin Sci Mol Med 1978;54:51-60.